the need to improve the quality of life of patients with aml undergoing allosct
Published 1 year ago • 66 plays • Length 2:17Download video MP4
Download video MP3
Similar videos
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
0:52
a real-world study of the optimal duration of cpx-351 treatment in patients with aml
-
0:58
current research and next steps to improve the understanding and management of icaht
-
0:46
simplify studies: analysis of the meaningful symptomatic change in patients with myelofibrosis
-
1:42
optimal sequencing of immunotherapies to improve outcomes for patients with multiple myeloma
-
1:06:53
aapb lecture | maximizing pbm through parameter optimization
-
4:23
newer treatment options in pv and how the therapeutic landscape is evolving
-
2:53
011 t- piece trial
-
1:15
key unmet needs in t-cell lymphoma: developing novel therapeutic strategies to improve outcomes
-
1:48
do all patients require maintenance therapy following allosct?
-
2:13
personalizing the timing of sct in patients with myelofibrosis
-
3:49
strategies to improve cost & access to car-t therapy
-
1:01
advancements in cml: improving treatment-free remission and novel agents
-
2:05
investigating the efficacy of tp-3654 in patients with myelofibrosis: results from phase i study
-
0:47
challenges in treating pv and optimal management strategies
-
3:17
how can we improve the cost-effectiveness of aml treatment?